Expression of TOP2A was associated with worse prognosis in melanoma.48 NEK2 was also identified as a regulator of aldehyde dehydrogenase 1, a marker of cancer-initiating cells,49 again linking stem cell function and drug resistance. This evidence concerns the gene NEK2 and cancer.